Skip to main content
Log in

Comment to the response to “Severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome”

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Wells DA, Loken MR (2012) Response to “Severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome”. Ann Hematol. doi:10.1007/s00277-012-1504-4

  2. Parmentier S, Meinel J, Oelschlaegel U, Mohr B, Ehninger G, Schaich M, Platzbecker U (2012) Severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome. Ann Hematol. doi:10.1007/s00277-012-1488-0

  3. Wells DA, Benesch M, Loken MR, Vallejo C, Myerson D, Leisenring WM, Deeg HJ (2003) Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation. Blood 102:394–403

    Article  PubMed  CAS  Google Scholar 

  4. van de Loosdrecht AA, Alhan C, Bene MC, Della Porta MG, Dräger AM, Feuillard J, Font P, Germing U, Haase D, Homburg CH, Ireland R, Jansen JH, Kern W, Malcovati L, te Marvelde JG, Mufti GJ, Ogata K, Orfao A, Ossenkoppele GJ, Porwit A, Preijers FW, Richards SJ, Schuurhuis GJ, Subirá D, Valent P, van der Velden VHJ, Vyas P, Westra AH, de Witte TM, Wells DA, Loken MR, Westers TM (2009) Standardization of flow cytometry in myelodysplastic syndromes: report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes. Haematologica 94:1124–1134

    Article  PubMed  Google Scholar 

  5. van de Loosdrecht AA, Westers TM, Westra AH, Dräger AM, van der Velden VHJ, Ossenkoppele GJ (2008) Identification of distinct prognostic subgroups in low- and intermediate-1-risk MDS by flow cytometry. Blood 111:1067–1077

    Article  PubMed  Google Scholar 

  6. Ogata K, Della Porta MG, Malcovati L, Picone C, Yokose N, Matsuda A, Yanasjita T, Tamura H, Tsukada J, Dan K (2009) Diagnostic utility of flow cytometry in myelodysplastic syndromes: a prospective validation study in low-risk patients with normal karyotype. Haematologica 94:1066–1074

    Article  PubMed  Google Scholar 

  7. Della Porta MG, Picone C, Pascutto C, Malcovati L, Tamura H, Handa H, Czader M, Freeman S, Vyas P, Porwit A, Saft L, Westers TM, Alhan C, Cali C, Van de Loosdrecht AA, Ogata K (2012) Multicentre validation of a reproducible flow cytometric score for the diagnosis of low-risk myelodysplastic syndromes: results of a European LeukemiaNET study. Haematologica. doi:10.3324/haematol.2011.048421

  8. Chu S-C, Wanga T-F, Li C-C, Kao R-H, Li D-K, Suc Y-C, Wells DA, Loken MR (2011) Flow cytometric scoring system as a diagnostic and prognostic tool in myelodysplastic syndromes. Leuk Res 35:868–873

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Uta Oelschlaegel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oelschlaegel, U., Parmentier, S. & Platzbecker, U. Comment to the response to “Severe pernicious anemia with distinct cytogenetic and flow cytometric aberrations mimicking myelodysplastic syndrome”. Ann Hematol 92, 575–576 (2013). https://doi.org/10.1007/s00277-012-1570-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1570-7

Keywords

Navigation